Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | JAK2 |
| Upstream (Parents) |
|---|
| (<<) BCL6 → JAK2 |
| (<<) BMPR1A → JAK2 |
| (<<) CASP6 → JAK2 |
| (<<) CLEC2B → JAK2 |
| (<<) ENO3 → JAK2 |
| (<<) FAS → JAK2 |
| (<<) GYS1 → JAK2 |
| (<<) HOPX → JAK2 |
| (<<) LIMK1 → JAK2 |
| (<<) MT3 → JAK2 |
| (<<) NAB2 → JAK2 |
| (<<) ODC1 → JAK2 |
| (<<) PLA2G6 → JAK2 |
| (<<) PRKAA1 → JAK2 |
| (<<) PSAT1 → JAK2 |
| (<<) RXRG → JAK2 |
| (<<) SEMA3A → JAK2 |
| (<<) SH3GLB1 → JAK2 |
| (<<) SPATA2L → JAK2 |
| (<<) ST3GAL6 → JAK2 |
| (<<) STEAP1 → JAK2 |
| Downstream (Children) |
|---|
| JAK2 → EREG (>>) |
| JAK2 → HCN2 (>>) |
| JAK2 → ORM1 (>>) |
| JAK2 → PLD1 (>>) |
